Regulation of fetal growth: Consequences and impact of being born small

Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 22, Issue 1, 2008, Pages 173-190

  Mullis, Primus E ^a   Tonella, Paolo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

catch up growth; fetus; growth; growth factor; insulin; placenta

Indexed keywords

CHORIONIC GONADOTROPIN; GROWTH FACTOR; GROWTH HORMONE; INSULIN; PLACENTAL PEPTIDE HORMONE; RECOMBINANT GROWTH HORMONE; RECOMBINANT LEPTIN; SOMATOMEDIN;

BODY WEIGHT; CATCH UP GROWTH; CHROMOSOME ABERRATION; FETAL MALNUTRITION; FETOPLACENTAL UNIT; FETUS GROWTH; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; GENOME IMPRINTING; GENOTYPE ENVIRONMENT INTERACTION; GESTATION PERIOD; GROWTH REGULATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; INFANCY; INSULIN RELEASE; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; MATERNAL NUTRITION; MATERNAL SMOKING; NONHUMAN; OBESITY; ORGANOGENESIS; PERINATAL PERIOD; PLACENTA FUNCTION; PREGNANCY; PRENATAL DEVELOPMENT; PUBERTY; REVIEW; SHORT STATURE; SMALL FOR DATE INFANT; UNSPECIFIED SIDE EFFECT;

CHROMOSOME ABERRATIONS; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; GROWTH HORMONE; HORMONES; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; PLACENTAL HORMONES; SOMATOMEDINS;

EID: 38949215389     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2007.07.010     Document Type: Review

References (126)

1. Tanner J.M. Fetus into Man: Physical Growth from Conception to Maturity. 2nd edn (1978), Harvard University Press, Cambridge, MA
2. Arey L.B. Developmental Anatomy. 7th edn (1966), W.B. Saunders, Philadelphia
3. de Pablo F., Scott L.A., and Roth J. Insulin and insulin-like-growth factor I in early development: peptides, receptors and biological events. Endocrine Reviews 11 (1990) 558-577
4. Bryan S.M., and Hindmarsh P.C. Normal and abnormal fetal growth. Hormone Research 65 Suppl 3 (2006) 19-27
5. Bakketeig L.S. Current growth standards, definitions, diagnosis and classification of fetal growth retardation. European Journal of Clinical Nutrition 52 Suppl 1 (1998) 1-4
6. Singer D.B., Sung C.J., and Wigglesworth J.S. Fetal growth and maturation. In: Wigglesworth J.S., and Singer D.B. (Eds). Textbook of Fetal and Perinatal Pathology (1996), Blackwell Scientific, Publications, Boston 11-47
7. Bakketeig L.S., Butte N., de Onis M., et al. Report of the IDECG Working Group on definitions, classifications, causes, mechanisms and prevention of IUGR. European Journal of Clinical Nutrition 52 Suppl 1 (1998) 94-96
8. Hindmarsh P.C., Geary M.P., Rodeck C.H., et al. Intrauterine growth and its relationship to size and shape at birth. Pediatric Research 52 (2002) 263-268
9. Gluckman P.D., and Hanson M.A. The consequences of being born small - an adaptive response. Hormone Research 65 Suppl 3 (2006) 5-14
10. Ounsted M., Scott A., and Moar V.A. Constrained and unconstrained fetal growth: associations with some biological and pathological factors. Annals of Human Biology 15 (1988) 119-129
11. Drake A.J., Walker B.R., and Seckl J.R. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 (2005) 34-38
12. Drake A.J., and Walker B.R. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. The Journal of Endocrinology 180 (2004) 1-16
13. Haig D. Genetic conflicts in human pregnancy. The Quarterly Review of Biology 68 (1993) 495-532
14. Haig D. Alteration of generations: genetic conflicts of pregnancy. American Journal of Reproductive Immunology 35 (1996) 226-232
15. Gluckman P.D., Hanson M.A., Spencer H.G., et al. Proceedings Biological Sciences 272 (2005) 671-677
16. Gluckman P.D., and Hanson M.A. Maternal constraint of fetal growth and its consequences. Seminars in Fetal & Neonatal Medicine 9 (2004) 419-425
17. Bauer M.K., Harding J.E., Bassett N.S., et al. Fetal growth and placental function. Molecular and Cellular Endocrinology 140 (1998) 115-120
18. Gluckman P.D., and Hanson M.A. Living with the past: evolution, development, and patterns of disease. Science 305 (2004) 1733-1736
19. Lillycrop K.A., Phillips E.S., Jackson A.A., et al. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. The Journal of Nutrition 135 (2005) 1382-1386
20. Bloomfield F.H., Oliver M.H., Giannoulias C.D., et al. Brief under-nutrition in late-gestation sheep programs the hypothalamic-pituitary-adrenal axis in adult offspring. Endocrinology 144 (2003) 2933-2940
21. Oliver M.H., Bloomfield F.H., Harding J.E., et al. The maternal, fetal and postnatal somatotrophic axes in intrauterine growth retardation. Biochemical Society Transactions 27 (1999) 69-73
22. Langley-Evans S.C., Phillips G.J., Benediktsson R., et al. Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta 17 (1996) 169-172
23. Gluckman P.D., and Harding J.E. Fetal growth retardation: underlying endocrine mechanisms and postnatal consequences. Acta Paediatrica 422 (1997) 69-72
24. Butler N.R., Goldstein H., and Ross E.M. Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. British Medical Journal 2 (1972) 127-130
25. Geary M., Crowley D., and Boylan P. Passive cigarette smoking in pregnancy. Journal of Obstetrics and Gynaecology 17 (1997) 264-265
26. Kalousek D.K., and Vekemans M. Confined placental mosaicism. Journal of Medical Genetics 33 (1996) 529-533
27. Monk D., Bentley L., Hitchins M., et al. Chromosome 7p disruptions in Silver Russell syndrome: delineating an imprinted candidate gene region. Human Genetics 111 (2002) 376-387
28. Walton A., and Hammond J. The maternal effects on growth and confirmation in Shire horse-Shetland pony crosses. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character 125 (1938) 311-335
29. Hitchins M.P., and Moore G.E. Genomic imprinting in fetal growth and development. Expert Reviews in Molecular Medicine 2002 (2002) 1-19
30. Reik W., Davies K., Dean W., et al. Imprinted genes and the coordination of fetal and postnatal growth in mammals. Novartis Foundation Symposium 237 (2001) 19-31
31. Constancia M., Kelsey G., and Reik W. Resourceful imprinting. Nature 432 (2004) 53-57
32. Tycko B., and Morison I.M. Physiological functions of imprinted genes. Journal of Cellular Physiology 192 (2002) 245-258
33. Fowden A.L., Sibley C., Reik W., et al. Imprinted genes, placental development and fetal growth. Hormone Research 65 Suppl 3 (2006) 50-58
34. Moore T. Genetic conflict, genomic imprinting and establishment of the epigenotype in relation to growth. Reproduction 122 (2001) 185-193
35. Gicquel C., and Le Bouc Y. Hormonal regulation of fetal growth. Hormone Research 65 Suppl 3 (2006) 28-33
36. Gaston V., Le Bouc Y., Soupre V., et al. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. European Journal of Human Genetics 9 (2001) 409-418
37. DeChiara T.M., Robertson E.J., and Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64 (1991) 849-859
38. DeChiara T.M., Efstratiadis A., and Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345 (1990) 78-80
39. Wang Z.Q., Fung M.R., Barlow D.P., et al. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372 (1994) 464-467
40. Ludwig T., Eggenschwiler J., Fisher P., et al. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Developmental Biology 177 (1996) 517-535
41. Woods K.A., Camacho-Hubner C., Savage M.O., et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. The New England Journal of Medicine 335 (1996) 1363-1367
42. Rosenfeld R.G. Molecular mechanisms of IGF-I deficiency. Hormone Research 65 Suppl 1 (2006) 15-20
43. Rosenfeld R.G. The IGF system: new developments relevant to pediatric practice. Endocrine Development 9 (2005) 1-10
44. Magnus P. Causes of variation in birth weight: a study of offspring of twins. Clinical Genetics 25 (1984) 15-24
45. Magnus P., Berg K., Bjerkedal T., et al. Parental determinants of birth weight. Clinical Genetics 26 (1984) 397-405
46. Magnus P. Further evidence for a significant effect of fetal genes on variation in birth weight. Clinical Genetics 26 (1984) 289-296
47. Arends N., Johnston L., Hokken-Koelega A., et al. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). The Journal of Clinical Endocrinology and Metabolism 87 (2002) 2720
48. Vaessen N., Janssen J.A., Heutink P., et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 359 (2002) 1036-1037
49. Johnston L.B., Dahlgren J., Leger J., et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 4805-4810
50. Hattersley A.T., Beards F., Ballantyne E., et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genetics 19 (1998) 268-270
51. Dunger D.B., Ong K.K., Huxtable S.J., et al. Association of the INS VNTR with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Nature Genetics 19 (1998) 98-100
52. Hattersley A.T., and Tooke J.E. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 353 (1999) 1789-1792
53. Mullis P.E. Genetic control of growth. European Journal of Endocrinology 152 (2005) 11-31
54. Kaplan S.L., Grumbach M.M., and Shepard T.H. The ontogenesis of human fetal hormones. I. Growth hormone and insulin. The Journal of Clinical Investigation 51 (1972) 3080-3093
55. Frankenne F., Closset J., Gomez F., et al. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. The Journal of Clinical Endocrinology and Metabolism 66 (1988) 1171-1180
56. de Zegher F., Vanderschueren-Lodeweyckx M., Spitz B., et al. Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH. The Journal of Clinical Endocrinology and Metabolism 77 (1990) 520-522
57. Hindmarsch P. Hormonal levels in the human fetus between 14 and 22 weeks gestation. Early Human Development 15 (1987) 253-258
58. Lassare C., Hardouin S., Daffos F., et al. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatric Research 29 (1991) 219-225
59. Giudice L.C., de Zegher F., Gargosky S.E., et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 1548-1555
60. de Zegher F., Bettendorf M., Kaplan S.L., et al. Hormone ontogeny in the ovine fetus and neonatal lamb. XXI. Effect of exogenous insulin-like growth factor-1 on plasma growth hormone, insulin and glucose concentrations. Endocrinology 123 (1988) 658-660
61. de Zegher F., Pernasetti F., Vanhole C., et al. The prenatal role of thyroid hormone evidenced by fetomaternal pit-1 deficiency. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 3127-3130
62. Parkes M.J., and Bassett J.M. Antagonism by growth hormone of insulin action in fetal sheep. The Journal of Endocrinology 105 (1985) 379-382
63. Stevens D., and Alexander G. Lipid deposition after hypophysectomy and growth hormone treatment in the sheep fetus. Journal of Developmental Physiology 8 (1986) 139-145
64. de Zegher F., Francois I., van Helvoirt M., et al. Clinical review 89: Small as fetus and short as child: from endogenous to exogenous growth hormone. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 2021-2026
65. Deiber M., Chatelain P., Naville D., et al. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. The Journal of Clinical Endocrinology and Metabolism 68 (1989) 232-234
66. Bauer M.K., Breier B.B., Bloomfield F.H., et al. Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth. Journal of Endocrinology 177 (2003) 83-92
67. Cianfarani S., Geremia C., Scott C.D., et al. Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis?. Pediatric Research 51 (2002) 94-99
68. Bloomfield F.H., van Zijl P.L., Bauer M.K., et al. Effect of pulsatile growth hormone administration to the growth-restricted fetal sheep on somatotrophic axis gene expression in fetal and placental tissues. American Journal of Physiology Endocrinology and Metabolism 291 (2006) E333-E339
69. Fleenor D., Oden J., Kelly P.A., et al. Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology 146 (2005) 103-112
70. Freemark M., Driscoll P., Maaskant R., et al. Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development. The Journal of Clinical Investigation 99 (1997) 1107-1117
71. Freemark M. The roles of growth hormone, prolactin and placental lactogen in human fetal development. In: Handweger S. (Ed). Molecular and Cellular Pediatric Endocrinology (1999), Humana, Totowa NJ 57-84
72. Chen E.Y., Liao Y.C., Smith D.H., et al. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 4 (1989) 479-497
73. Goossens M., Brauner R., Czernichow P., et al. Isolated growth hormone (GH) deficiency type 1A associated with a double deletion in the human GH gene cluster. The Journal of Clinical Endocrinology and Metabolism 62 (1986) 712-716
74. Akinci A., Kanaka C., Eble A., et al. Isolated growth hormone (GH) deficiency type IA associated with a 45-kilobase gene deletion within the human GH gene cluster. The Journal of Clinical Endocrinology and Metabolism 75 (1992) 437-441
75. Parks J.S., Nielsen P.V., Sexton L.A., et al. An effect of gene dosage on production of human chorionic somatomammotropin. The Journal of Clinical Endocrinology and Metabolism 60 5 (1985) 994-997
76. Simon P., Decoster C., Brocas H., et al. Absence of human chorionic somatomammotropin during pregnancy associated with two types of gene deletion. Human Genetics 74 (1986) 235-238
77. Fall C.H., Pandit A.N., Law C.M., et al. Size at birth and plasma insulin-like growth factor-1 concentrations. Archives of Disease in Childhood 73 (1995) 287-293
78. Green L.R., Kawagoe Y., Hill D.J., et al. The effect of intermittent umbilical cord occlusion on insulin-like growth factors and their binding proteins in preterm and near-term ovine fetuses. Journal of Endocrinology 166 (2000) 565-577
79. Jaquet D., Leger J., Levy-Marchal C., et al. Ontogeny of leptin in human fetuses and newborns: effect of intrauterine growth retardation on serum leptin concentrations. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 1243-1246
80. Yang S.W., and Yu J.S. Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birthweight. Pediatric International 42 (2000) 31-36
81. Ozkan H., Aydin A., Demir N., et al. Associations of IGF-I, IGFBP-1 and IGFBP-3 on intrauterine growth and early catch-up growth. Biology of the Neonate 76 (1999) 274-282
82. Albertsson-Wikland K., Boguszewski M., and Karlberg J. Children born small-for-gestational age: postnatal growth and hormonal status. Hormone Research 49 Suppl 2 (1998) 7-13
83. Barker D.J. Intrauterine programming of adult diseases. Molecular Medicine Today 1 (1995) 418-423
84. Hales C.N., and Barker D.J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35 (1992) 595-601
85. Hales C.N., and Barker D.J. The thrifty phenotype hypothesis. British Medical Bulletin 60 (2001) 5-20
86. Bloomfield F.H., Oliver M.H., and Harding J.E. The late effects of fetal growth patterns. Archives of Disease in Childhood Fetal and Neonatal Edition 91 (2006) F299-F304
87. Plagemann A. Perinatal nutrition and hormone-dependent programming of food intake. Hormone Research 65 Suppl 3 (2006) 83-89
88. Stoffers D.A., Zinkin N.T., Stanojevic V., et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nature Genetics 15 (1997) 106-110
89. Elsas L.J., Endo F., Strumlauf E., et al. Leprechaunism: an inherited defect in a high-affinity insulin receptor. American Journal of Human Genetics 37 (1985) 73-88
90. Randle P.J. Glucokinase and candidate genes for type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 269-275
91. Velho G., Petersen K.F., Perseghin G., et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. The Journal of Clinical Investigation 98 (1996) 1755-1761
92. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia 42 (1999) 1033-1049
93. Eriksson J.G., Lindi V., Uusitupa M., et al. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes 51 (2002) 2321-2324
94. Gesina E., Blondeau B., Milet A., et al. Glucocorticoid signalling affects pancreatic development through both direct and indirect effects. Diabetologia 49 (2006) 2939-2947
95. Breant B., Gesina E., and Blondeau B. Nutrition, glucocorticoids and pancreas development. Hormone Research 65 Suppl 3 (2006) 98-104
96. Ravelli G.P., Stein Z.A., and Susser M.W. Obesity in young men after famine exposure in utero and early infancy. The New England Journal of Medicine 295 (1976) 349-353
97. Plagemann A., Harder T., Rake A., et al. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Research 836 (1999) 146-155
98. Plagemann A., Harder T., Rake A., et al. Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rats. Journal of Neuroendocrinology 11 (1999) 541-546
99. Dulloo A.G., Jacquet J., Seydoux J., et al. The thrifty 'catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. International Journal of Obesity 30 Suppl 4 (2006) S23-S35
100. Dulloo A.G. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity. Hormone Research 65 Suppl 3 (2006) 90-97
101. Dulloo A.G., Jacquet J., and Montani J.P. Pathways from weight fluctuations to metabolic diseases: focus on maladaptive thermogenesis during catch-up fat. International Journal of Obesity and Related Metabolic Disorders 26 Suppl 2 (2002) S46-S57
102. Hofman P.L., Cutfield W.S., Robinson E.M., et al. Insulin resistance in short children with intrauterine growth retardation. The Journal of Clinical Endocrinology and Metabolism 82 (1997) 402-406
103. Jornayvaz F.R., Selz R., Tappy L., et al. Metabolism of oral glucose in children born small for gestational age: evidence for an impaired whole body glucose oxidation. Metabolism 53 (2004) 847-851
104. Cettour-Rose P., Samec S., Russell A.P., et al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: a link between catch-up growth and later metabolic syndrome. Diabetes 54 (2005) 751-756
105. Dulloo A.G. A role for suppressed skeletal muscle thermogenesis in pathways from weight fluctuations to the insulin resistance syndrome. Acta Physiologica Scandinavica 184 (2005) 295-307
106. Crescenzo R., Samec S., Antic V., et al. A role for suppressed thermogenesis favoring catch-up fat in the pathophysiology of catch-up growth. Diabetes 52 (2003) 1090-1097
107. Barker D.J. In utero programming of chronic disease. Clinical Science 95 (1998) 115-128
108. van Weissenbruch M.M., and Delemarre-van de Waal H.A. Early influences on the tempo of puberty. Hormone Research 65 Suppl 3 (2006) 105-111
109. Weaver I.C., Cervoni N., Champagne F.A., et al. Epigenetic programming by maternal behavior. Nature Neuroscience 7 (2004) 847-854
110. Vickers M.H., Gluckman P.D., Coveny A.H., et al. Neonatal leptin treatment reverses developmental programming. Endocrinology 146 (2005) 4211-4216
111. Yura S., Itoh H., Sagawa N., et al. Role of premature leptin surge in obesity resulting from intrauterine under-nutrition. Cell Metabolism 1 (2005) 371-378
112. Farooqi I.S., and O'Rahilly S. New advances in the genetics of early onset obesity. International Journal of Obesity 29 (2005) 1149-1152
113. Tanner J.M. Growth from birth to two: a critical review. Acta Medica Auxologica 26 (1994) 7-45
114. Karlberg J., and Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatric Research 38 (1995) 733-739
115. Albertsson-Wikland K., and Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatrica Scandinavica 399 Suppl (1994) 64-70
116. Hokken-Koelega A.C., De Ridder M.A., Lemmen R.J., et al. Children born small for gestational age: do they catch up?. Pediatric Research 38 (1995) 267-271
117. Albertsson-Wikland K., Wennergren G., Wennergren M., et al. Longitudinal follow-up of growth in children born small for gestational age. Acta Paediatrica 82 (1993) 438-443
118. Luo Z.C., Albertsson-Wikland K., and Karlberg J. Length and body mass index at birth and target height influences on patterns of postnatal growth in children born small for gestational age. Pediatrics 102 (1998) E72
119. Ibanez L., Ferrer A., Marcos M.V., et al. Early puberty: rapid progression and reduced final height in girls with low birth weight. Pediatrics 106 5 (2000) E72
120. Cook C.J., Gluckman P.D., Williams C., et al. Precocial neural function in the growth-retarded fetal lamb. Pediatric Research 24 (1988) 600-604
121. Ibanez L., and de Zegher F. Puberty and prenatal growth. Molecular and Cellular Endocrinology 254-255 (2006) 22-25
122. Ibanez L., and de Zegher F. Puberty after prenatal growth restraint. Hormone Research 65 Suppl 3 (2006) 112-115
123. Ducharme J.R., and Grumbach M.M. Studies on the effects of human growth hormone in premature infants. The Journal of Clinical Investigation 40 (1961) 243-247
124. van Toledo-Eppinga L. Growth promoting interventions in preterm infants. PhD Thesis. Amsterdam: Free University Amsterdam; 1995.
125. de Zegher F., Ong K.K., Ibanez L., et al. Growth hormone therapy in short children born small for gestational age. Hormone Research 65 Suppl 3 (2006) 145-152
126. Cutfield W.S., Lindberg A., Rapaport R., et al. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis. Hormone Research 65 Suppl 3 (2006) 153-159